These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy. Velez G; Yang J; Li AS; Tsang SH; Bassuk AG; Mahajan VB Sci Rep; 2019 May; 9(1):7608. PubMed ID: 31110225 [TBL] [Abstract][Full Text] [Related]
5. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment. Ricker LJ; Dieri RA; Beckers GJ; Pels E; Liem AT; Hendrikse F; Kijlstra A; Hemker HC; La Heij EC Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588 [TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment. Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637 [TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051 [TBL] [Abstract][Full Text] [Related]
8. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976 [TBL] [Abstract][Full Text] [Related]
9. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment]. Terasaki H Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405 [TBL] [Abstract][Full Text] [Related]
10. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518 [TBL] [Abstract][Full Text] [Related]
12. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis. Yu J; Peng R; Chen H; Cui C; Ba J Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279 [TBL] [Abstract][Full Text] [Related]
13. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment. Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670 [TBL] [Abstract][Full Text] [Related]
14. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment. Mulder VC; Bastiaans J; van Leuven CJM; van Meurs JC; Kluft C Ophthalmologica; 2018; 240(1):23-28. PubMed ID: 29617690 [TBL] [Abstract][Full Text] [Related]
15. Investigating the pathological processes of rhegmatogenous retinal detachment and proliferative vitreoretinopathy with metabolomics analysis. Li M; Li H; Jiang P; Liu X; Xu D; Wang F Mol Biosyst; 2014 May; 10(5):1055-62. PubMed ID: 24556753 [TBL] [Abstract][Full Text] [Related]
16. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070 [TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605 [TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001 [TBL] [Abstract][Full Text] [Related]
20. iTRAQ Quantitative Proteomic Analysis of Vitreous from Patients with Retinal Detachment. Santos FM; Gaspar LM; Ciordia S; Rocha AS; Castro E Sousa JP; Paradela A; Passarinha LA; Tomaz CT Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]